Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 41 | $15,414,881 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
15 Mar 2024 18:39 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 13 Mar 2024 | Sale | 36,116 | 33.48 | 1,209,164 | D |
15 Mar 2024 18:39 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 13 Mar 2024 | Sale | 26,250 | 34.1 | 895,125 | D |
14 Mar 2024 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 12 Mar 2024 | Sale | 3,884 | 32.99 | 128,133 | D |
28 Feb 2024 17:01 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 26 Feb 2024 | Sale | 5,000 | 30.21 | 151,050 | D |
12 Jan 2024 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | MARTIN TAMI TILLOTSON | Sr. V.P., Regulatory Affairs | 10 Jan 2024 | Sale | 8,000 | 27.91 | 223,280 | D |
20 Nov 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | NEWHALL CHARLES W III | Director | 16 Nov 2023 | Sale | 2,500 | 28.01 | 70,025 | D |
17 Nov 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | HUDSON FREDERICK M. | Director | 15 Nov 2023 | Sale | 5,211 | 28.5 | 148,514 | D |
17 Nov 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | HUDSON FREDERICK M. | Director | 15 Nov 2023 | Sale | 3,882 | 28.5 | 110,637 | D |
16 Nov 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | MOTTOLA FRANK | SVP, Quality, GMP, Ops, IT | 14 Nov 2023 | Sale | 1,110 | 28.13 | 31,224 | D |
25 Mar 2024 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 21 Mar 2024 | Sale | 14,491 | 35.31 | 511,677 | D |
22 Mar 2024 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 20 Mar 2024 | Sale | 400 | 35.31 | 14,124 | D |
21 Mar 2024 17:01 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 19 Mar 2024 | Sale | 12,364 | 35.31 | 436,573 | D |
01 Sep 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | MARTIN TAMI TILLOTSON | Sr. V.P., Regulatory Affairs | 30 Aug 2023 | Sale | 8,100 | 32 | 259,200 | D |
29 Aug 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | MARTIN TAMI TILLOTSON | Sr. V.P., Regulatory Affairs | 25 Aug 2023 | Sale | 5,135 | 31.59 | 162,215 | D |
16 Mar 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | MOTTOLA FRANK | Sr VP, Quality, GMP Oper. & IT | 14 Mar 2023 | Sale | 4,780 | 35.988 | 172,023 | D |
06 Feb 2023 17:01 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 03 Feb 2023 | Sale | 200 | 42.02 | 8,404 | D |
06 Feb 2023 17:01 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 02 Feb 2023 | Sale | 13,532 | 42.055 | 569,088 | D |
03 Feb 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 01 Feb 2023 | Sale | 300 | 42.0067 | 12,602 | D |
02 Feb 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 31 Jan 2023 | Sale | 976 | 42.0106 | 41,002 | D |
20 Jan 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 18 Jan 2023 | Sale | 4,936 | 40.3959 | 199,394 | D |
19 Jan 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 17 Jan 2023 | Sale | 25,446 | 40.0349 | 1,018,728 | D |
19 Jan 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 17 Jan 2023 | Sale | 4,826 | 39.9167 | 192,638 | D |
09 Jan 2023 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 06 Jan 2023 | Sale | 174 | 39.9 | 6,943 | D |
22 Dec 2022 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 21 Dec 2022 | Sale | 11,354 | 38.1425 | 433,070 | D |
22 Dec 2022 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 20 Dec 2022 | Sale | 4,006 | 38.0222 | 152,317 | D |
02 Dec 2022 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 01 Dec 2022 | Sale | 5,000 | 37.4832 | 187,416 | D |
28 Nov 2022 17:02 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 25 Nov 2022 | Sale | 11,135 | 35.176 | 391,685 | D |
28 Nov 2022 17:02 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 23 Nov 2022 | Sale | 2,259 | 35.0548 | 79,189 | D |
23 Nov 2022 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 22 Nov 2022 | Sale | 600 | 35.0018 | 21,001 | D |
22 Nov 2022 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 21 Nov 2022 | Sale | 531 | 35.0136 | 18,592 | D |
17 Nov 2022 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 15 Nov 2022 | Sale | 1,115 | 35.0027 | 39,028 | D |
15 Nov 2022 17:01 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 11 Nov 2022 | Sale | 6,800 | 34.9493 | 237,655 | D |
14 Nov 2022 17:00 | SUPN | SUPERNUS PHARMACEUTICALS Inc | BHATT PADMANABH P. | Sr. VP of IP, CSO | 09 Nov 2022 | Sale | 700 | 34.9713 | 24,480 | D |
23 Aug 2022 17:16 | SUPN | SUPERNUS PHARMACEUTICALS Inc | MARTIN TAMI TILLOTSON | Sr. V.P., Regulatory Affairs | 22 Aug 2022 | Sale | 5,000 | 35.98 | 179,900 | D |
18 Aug 2022 17:15 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 16 Aug 2022 | Sale | 14,690 | 34.013 | 499,651 | D |
17 Aug 2022 16:27 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 15 Aug 2022 | Sale | 17,302 | 34.028 | 588,752 | D |
11 Aug 2022 17:15 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 10 Aug 2022 | Sale | 28,437 | 31.22 | 887,803 | D |
10 Aug 2022 17:25 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 09 Aug 2022 | Sale | 39,431 | 31.15 | 1,228,276 | D |
09 Aug 2022 17:25 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 08 Aug 2022 | Sale | 10,032 | 32.11 | 322,128 | D |
09 Aug 2022 17:25 | SUPN | SUPERNUS PHARMACEUTICALS Inc | KHATTAR JACK A. | President, CEO | 08 Aug 2022 | Sale | 107,875 | 31.4 | 3,387,275 | D |
05 Aug 2022 16:31 | SUPN | SUPERNUS PHARMACEUTICALS Inc | MARTIN TAMI TILLOTSON | Sr. V.P., Regulatory Affairs | 04 Aug 2022 | Sale | 5,000 | 32.98 | 164,900 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)